Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05319_nanopub.RAIJYTQWBRjEYVzEL3RNFFNB82_iU4ZY5OWKbkeAea0fU#assertion>. }
Showing items 1 to 13 of
13
with 100 items per page.
- drugbank:DB05319 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05319 label "oportuzumab monatox [drugbank:DB05319]" assertion.
- drugbank:DB05319 seeAlso DB05319 assertion.
- drugbank:DB05319 description "VB4-845 is studied in the treatment of certain types of head and neck cancer. VB4-845 is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. VB4-845 is a fusion protein containing humanized scFv specific for the epithelial cell adhesion molecule, Ep-CAM, a tumor cell-associated target highly expressed on carcinoma cells of epithelial origin and a truncated portion of Pseudomonas exotoxin A." assertion.
- drugbank:DB05319 identifier "drugbank:DB05319" assertion.
- drugbank:DB05319 title "oportuzumab monatox" assertion.
- drugbank:DB05319 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05319 drugbank_vocabulary:drugbank-id "DB05319" assertion.
- drugbank:DB05319 bio2rdf_vocabulary:x-identifiers.org DB05319 assertion.
- drugbank:DB05319 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05319" assertion.
- drugbank:DB05319 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05319 bio2rdf_vocabulary:identifier "DB05319" assertion.
- drugbank:DB05319 drugbank_vocabulary:x-wikipedia wikipedia:Oportuzumab_monatox assertion.